AU4365796A - Methods for inhibiting cell proliferation by inhibiting the mitogenic activity of macrophage migration inhibitory factor - Google Patents

Methods for inhibiting cell proliferation by inhibiting the mitogenic activity of macrophage migration inhibitory factor

Info

Publication number
AU4365796A
AU4365796A AU43657/96A AU4365796A AU4365796A AU 4365796 A AU4365796 A AU 4365796A AU 43657/96 A AU43657/96 A AU 43657/96A AU 4365796 A AU4365796 A AU 4365796A AU 4365796 A AU4365796 A AU 4365796A
Authority
AU
Australia
Prior art keywords
inhibiting
methods
cell proliferation
inhibitory factor
mitogenic activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43657/96A
Inventor
Vishwas Paralkar
Graeme J Wistow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
US Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, US Government filed Critical US Department of Health and Human Services
Publication of AU4365796A publication Critical patent/AU4365796A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU43657/96A 1994-11-16 1995-11-16 Methods for inhibiting cell proliferation by inhibiting the mitogenic activity of macrophage migration inhibitory factor Abandoned AU4365796A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34082694A 1994-11-16 1994-11-16
US340826 1994-11-16
PCT/US1995/015000 WO1996015242A2 (en) 1994-11-16 1995-11-16 Methods for inhibiting cell proliferation by inhibiting the mitogenic activity of macrophage migration inhibitory factor

Publications (1)

Publication Number Publication Date
AU4365796A true AU4365796A (en) 1996-06-06

Family

ID=23335092

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43657/96A Abandoned AU4365796A (en) 1994-11-16 1995-11-16 Methods for inhibiting cell proliferation by inhibiting the mitogenic activity of macrophage migration inhibitory factor

Country Status (2)

Country Link
AU (1) AU4365796A (en)
WO (1) WO1996015242A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774227B1 (en) * 1993-05-17 2004-08-10 Cytokine Pharmasciences, Inc. Therapeutic uses of factors which inhibit or neutralize MIF activity
EP1051490A2 (en) * 1998-01-30 2000-11-15 Cold Spring Harbor Laboratory Modulation of cell proliferation, methods and reagents
WO2000006189A2 (en) * 1998-07-27 2000-02-10 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Conversion of naturally-occurring quinones to quinone derivatives by macrophage migration inhibition factor and uses thereof
US6268151B1 (en) * 2000-01-20 2001-07-31 Isis Pharmaceuticals, Inc. Antisense modulation of macrophage migration inhibitory factor expression
MY140679A (en) 2001-05-24 2010-01-15 Avanir Pharmaceuticals Inhibitors of macrohage migration inhibitory factor and methods for identifying the same
TW200418829A (en) 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
WO2006102191A1 (en) 2005-03-24 2006-09-28 Avanir Pharmaceuticals Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
US9958456B2 (en) 2011-10-07 2018-05-01 Baxalta Incorporated OxMIF as a diagnostic marker

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1741779A3 (en) * 1993-05-17 2010-03-24 The Picower Institute For Medical Research Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine mediated toxicity

Also Published As

Publication number Publication date
WO1996015242A2 (en) 1996-05-23
WO1996015242A3 (en) 1996-08-08

Similar Documents

Publication Publication Date Title
AU3052984A (en) Baking organic coating
AU7683391A (en) Modified interleukin-1 inhibitors
AU3958485A (en) Cooking system
AU1599795A (en) Cracking processes
AU582178B2 (en) Coated products
AU570822B2 (en) Regenerating corn
AU3769097A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
AU4296397A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
AU3827585A (en) Oven systems
AU7295196A (en) 4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
AU4989397A (en) Seismic activity predictor
AU7394294A (en) Macrophage migration inhibitory factor-3
AU613302B2 (en) Quinolyloxazole-2-ones useful as proteinkinase c inhibitors
AU4656289A (en) Substrate for polymerase activity determination
EP0599514A3 (en) Pyranoquinoline derivatives as inhibitors of cell proliferation.
PL337331A1 (en) Cyanoguanidines as cell proliferation inhibitors
AU7671198A (en) Methods for the inhibition of neuronal activity by local delivery of adenosi ne
AU4365796A (en) Methods for inhibiting cell proliferation by inhibiting the mitogenic activity of macrophage migration inhibitory factor
AU621181B2 (en) Immune cell proliferation inhibitors
HK1039116A1 (en) Cyanoguanidines as cell proliferation inhibitors
AU4117297A (en) N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity
AU7638498A (en) Cyanoguanidines as cell proliferation inhibitors
PL337031A1 (en) Cyanoguanidines as inhibitors of cell proliferation
AU4754685A (en) Camshaft detail
AU1806892A (en) Immune cell proliferation inhibitors